Skip to main content
PHAGE: Therapy, Applications, and Research logoLink to PHAGE: Therapy, Applications, and Research
. 2021 Mar 17;2(1):43–49. doi: 10.1089/phage.2020.0030

Isolation and Characterization of vB_MsmS_Celfi: A New Mycobacterium tuberculosis Bacteriophage

Florencia Payaslian 1,2, Victoria Gradaschi 1,2, Liliana Rondón Salazar 1,2, Maria Eugenia Dieterle 1,2, Estefanía Urdániz 1,2, Matias Di Paola 1,2, José Peña Cárcamo 1,2, Fabio Zon 1,2, Ezequiel Sosa 3, Darío Fernandez Do Porto 1,3, Matthew Dunne 4, Pauline Goeller 4, Jochen Klumpp 4, Raúl Ricardo Raya 5, Alejandro Reyes 6,7, Mariana Piuri 1,2,
PMCID: PMC9041486  PMID: 36148439

Abstract

Introduction: Because of the clinical relevance of Mycobacteria, and from a therapeutic perspective, there is an increasing interest to study phages that infect bacteria belonging to this genus.

Materials and Methods: A phage was isolated from a soil sample, using Mycobacterium smegmatis as host. Its characterization included sequencing, annotation, and analysis of the genome, host range determination, and electron microscopy imaging.

Results: Mycobacterium phage vB_MsmS_Celfi is a temperate phage able to infect Mycobacterium tuberculosis with high efficiency. From electron microscopy images, Celfi belongs to the Siphoviridae family. Genome analysis classified phage Celfi into cluster L, subcluster L2 of Actinobacteriophage clusters. Mycobacterium phage Celfi exhibits a Lysin B distant to those present in other members of the subcluster and other mycobacteriophages.

Conclusions: The discovery of new phages that infect M. tuberculosis could contribute to the development of novel tools for detection systems and future treatment of the disease.

Keywords: Mycobacterium phage, LysB, M. tuberculosis

Introduction

Mycobacterial species are responsible for a wide variety of infectious diseases, including leprosy, caused by Mycobacterium leprae, and tuberculosis caused by Mycobacterium tuberculosis. Nontuberculous mycobacteria (NTM) lung diseases (including those caused by Mycobacterium avium, Mycobacterium abscessus, and Mycobacterium fortuitum) are also increasingly recognized as opportunistic infections in humans.1,2 However, many mycobacteria are difficult to manipulate in laboratory conditions. For instance, M. tuberculosis requires incubation of 3 to 4 weeks at 37°C to form colonies, virulent strains have to be manipulated in a biosafety level III3 and M. leprae can only propagate in footpads of mice or in nine-banded armadillos.4 Owing to the relevance of members of this genus, mycobacteriophages, viruses that specifically infect Mycobacterium spp., are of special interest. Because many of them can replicate on Mycobacterium smegmatis, a fast-growing and easy-to-manipulate bacteria, mycobacteriophages and their proteins have become an attractive option to engineer mycobacterial genomes and for tuberculosis diagnosis.5–11

Most of the mycobacteriophages identified presently were isolated and sequenced in the context of the SEA-PHAGES (Science Education Alliance-Phage Hunters Advancing Genomics and Evolutionary Science) program. This program promotes the engagement of undergraduate students in research by the isolation and characterization of bacteriophages.12–14

The success of this program was a source of inspiration to carry out an International Phage Course at the University of Buenos Aires directed toward graduate students and young researchers from Latin America. During this 2-week course, students were able to isolate, sequence, and annotate the genomes of different bacteriophages from environmental samples (commentary in this issue).

In this study, we present one of those phages that was isolated from a soil sample from the outside field of the School of Exact and Natural Sciences, University of Buenos Aires where the course took place.

Materials and Methods

Mycobacterium phage vB_MsmS_Celfi (phage Celfi) was isolated from a soil sample from Buenos Aires, Argentina. In brief, ∼1 g of soil was incubated with phage buffer (10 mM Tris-HCl pH = 7.5; 68.5 mM NaCl; 10 mM MgSO4; 1 mM CaCl2), after vigorous mixing, the sample was centrifuged for 10 min at 4000 g and the supernatant was filtered using a 0.22 μm membrane. After enrichment in Middlebrock 7H9 medium supplemented with albumin dextrose complex (ADC) 10% (0.2% w/v dextrose; 0.085% w/v NaCl; 0.5% w/v bovine serum albumin) at 37°C with agitation at 250 rpm overnight at 37°C using M. smegmatis mc2155 as host, isolation and purification were carried out through the double layer assay as described by Kropinski et al.15 followed by five subsequent rounds of purification. High-titer stocks were prepared on solid media: 80 Petri dishes were incubated with a layer of top agar containing 100 μL of a culture of M. smegmatis mc2155 in exponential phase of growth and 100 μL of phage suspension containing ∼500–1000 plaque forming unit (PFU), sufficient to get confluent plaques but not complete lysis. Once plaques were obtained, plates were covered with phage buffer and incubated overnight at 4°C, then the top agar layer was scrapped, transferred to conical tubes, and centrifuged. The supernatant was filtered through a 0.22 μm membrane and concentrated by ultracentrifugation at 100,000 g for 3 h at 4°C.

Bacterial strains and culture conditions

M. smegmatis mc2155 was used as the isolation host and was cultured in Middlebrock 7H9 media supplemented with ADC 10% at 37°C with agitation at 250 rpm. For solid culture, Middlebrock 7H10 was used.

M. tuberculosis mc26230,16 Mycobacterium intracellulare, M. abscessus, M. avium, and Mycobacterium kansasii were manipulated under biosafety level 2 (BSL-2) conditions. The NTM strains are clinical isolates. All of these strains were cultured in 7H9 media supplemented with oleic acid albumin dextrose complex Enrichment (Becton, Dickinson and Company, Sparks, MD) and PANTA (Becton, Dickinson and Company) at 37°C without agitation. In particular, for M. tuberculosis mc26230, pantothenic acid (100 μg/mL) was added.

Because of the complex cell envelope, mycobacteria tend to form aggregates in liquid culture that are prevented by the addition of Tween 80 (0.05% v/v). Since this surfactant can abrogate mycobacteriophage infection, bacteria were cultured in the presence of Tween and extensively washed before infection.

Host range assay

To determine the host range, several mycobacteria species of clinical relevance were employed. Tenfold serial dilutions of the phage stock were performed in phage buffer. To do a spot test, 7H10 plates were poured with 5 mL of 7H10 top agar containing 100 μL of bacterial culture in exponential phase. Once the overlay solidified, 10 μL of each dilution was dispensed on the overlay. Plates were incubated at 37°C for 48 h in the case of M. smegmatis mc2155 or for 2–8 weeks for the rest of the strains to allow the correct growth of the lawn and plaque visualization.

When plaques were evident, phage titer was calculated according to

graphic file with name phage.2020.0030_inline1.jpg

Efficiency of plating (EoP) was calculated as the titer of the phage in a stated bacterial strain/the maximum phage titer observed.

DNA isolation and sequencing

DNA was extracted from a high-titer phage stock using a simple phenol–chloroform protocol as described on the Phage Hunters program website.17 DNA samples were sent for sequencing to a local facility. Genomic libraries were constructed using Nextera® XT DNA Sample Preparation Kit (Illumina) following the manufacturer's instructions. Individual libraries were indexed with Nextera XT Index Kit. Paired-end reads were obtained using Illumina MiSeq platform at the National Institute of Infectious Diseases “Dr. Carlos G. Malbran” (Buenos Aires, Argentina), which generated 133,300 250-bp paired-end raw reads. The adapter and low-quality sequences were trimmed, and short reads were filtered out using Trimmomatic software18 v 0.36 using default configurations. The trimmed reads were de novo assembled using Velvet 1.2.10.19

Bioinformatic analysis and annotation

Sequence analysis and annotation were performed using DNAMaster20 and curated manually. Start sites were found using Glimmer21 and GeneMark22; tRNAs were predicted using Aragorn23 and tRNA scan.24,25 Putative functions were assigned using BLAST26 and HHPred.27 Alignments and evolutionary analyses were conducted in MEGA X.28The evolutionary history was inferred by using the Maximum Likelihood method and JTT matrix-based model.29

Transmission electron microscopy

Phage morphology was assessed by transmission electron microscopy (TEM) in collaboration with the Laboratory of Food Microbiology at ETH Zurich. High titer phage stocks were negatively stained for 20 s with 2% uranyl acetate, pH 8.0, on carbon-coated copper grids (Quantifoil), and observed at 100 kV on a Hitachi HT 7700 scope equipped with an AMT XR81B Peltier cooled CCD camera (8M pixel). Only six suitable particles were measured for phage Celfi, and, therefore, only a range of size is provided.

Results

Mycobacterium phage vB_MsmS_Celfi (phage Celfi) was isolated after enrichment from a soil sample taken outside of the School of Exact and Natural Sciences, University of Buenos Aires, Argentina (34° 32′ S, 58° 26′ W), using M. smegmatis mc2155 as host.

Host range and morphology

Phage Celfi form plaques on M. smegmatis and M. tuberculosis strains, but not on the M. intracellulare, M. abscessus, M. avium, and M. kansasii strains tested (Table 1). Phage plaques on M. smegmatis mc2155 were mostly clear, big, and round, with a diameter of 1.63 ± 0.28 mm (Fig. 1A); however, its EoP on M. smegmatis mc2155 was 1.3 10−1 compared with the M. tuberculosis mc26230 strain.

Table 1.

Host Range of Mycobacterium Phage Centro Latinoamericano de Formación Interdisciplinaria

Mycobacterium spp. EoP
M. smegmatis mc2155 1.3 10−1
M. tuberculosis mc26230 1
M. intracellulare a *
M. abscessus a *
M. avium a *
M. kansasii a *
*

Absence of individual plaques.

a

Clinical isolates.

EoP, efficiency of plating.

FIG. 1.

FIG. 1.

Mycobacterium phage Celfi belongs to the Siphoviridae family. (A) Plaques of Mycobacterium phage CELFI on Mycobacterium smegmatis mc2155. (B) and (C) TEM images of CELFI phage. Magnification 60.0 k. CELFI, Centro Latinoamericano de Formación Interdisciplinaria; TEM, transmission electron microscopy.

Morphologically, phage Celfi is a Siphovirus. Virion particles of phage Celfi have an icosahedral head (head diameter range 61–69 nm) and a long noncontractile tail (tail length range 189–246 nm; Fig. 1B, C).

Sequencing and genome organization

Phage Celfi genome consists of a double-stranded DNA molecule of 77086 bp (125-fold coverage) with an overall guanine cytosine (GC) content of 59%. Genome analysis revealed 133 potential coding DNA sequences, 122 open-reading genes (ORFs), and 11 tRNA genes: 97 ORFs are transcribed rightward and 25 are transcribed leftward. The most commonly used start codon is ATG (50.4%), with lower usage of GTG (30.1%) and TTG (19.5%). The genome organization can be divided into the following modules: DNA packaging, virion structure, lysis, integration, immunity, and replication; a schematic representation is shown in Figure 2, and a list of predicted genes and gene products is available in Supplementary Table S1.

FIG. 2.

FIG. 2.

Schematic representation of Mycobacterium phage CELFI genome. The viral genome is represented in three tiers, with markers spaced at 100 bp intervals. The predicted genes are shown as boxes either above or below the genome, depending on whether they are rightward (green boxes) or leftward (red boxes) transcribed. tRNAs are shown in blue. Gene numbers are shown within each box.

The sequences were deposited in GenBank under the accession number MT758688.

Comparative genome analysis

DNA sequence analysis indicated that phage Celfi belongs to the Siphoviridae family, Bronvirus genus, and to cluster L, subcluster L2 of Actinobacteriophage clusters.13,14,30 Genomes of phages belonging to subcluster L2 have an average length of 75507 bp and GC% of 58.9. Average nucleotide sequence identity of phage Celfi with the other 25 phages in subcluster L2 is 92–94% (Ref.31). Interestingly, the closest match was with a prophage present in Mycobacterium sp. DL90 chromosome (NZ_CP034072.1) (93.9% identity). Even though Mycobacterium sp. DL90 genome has not been annotated, we were able to identify that the prophage is integrated into a putative tRNA gene. Phage Celfi, similar to other phages in the subcluster L2, encodes a tyrosine integrase. A putative attP site upstream the integrase gene was identified in the DNA of phage Celfi (pos 31626–31655), and a predictive attB site for phage Celfi in a tRNALys gene (coordinates 5834590–5834620 in M. smegmatis mc2155 genome) was found. In addition to the integrase gene (gene 37), two transcriptional regulators (a putative immunity repressor, gene 39, and putative Cro protein, gene 40) and a putative excisionase (gene 41) could be identified in Celfi´s genome. All these data suggest that phage Celfi is a temperate phage. In agreement with this, we spotted a few turbid plaques in lawns of M. smegmatis mc2155. Sequence analysis comparison with two closely related phages (MkaliMitinis3 and Guuelad) and the Mycobacterium sp. DL90 prophage suggests that bacteriophage Celfi has cohesive ends with a common canonical cohesive site sequence: TCGATCAGCC; however, direct sequencing evidence falls four nucleotides short to cover the cohesive end site, which is expected due to the mechanisms of library construction. Further experiments and sequencing of the genome ends should be performed to corroborate this and report this sequence unequivocally.

As found in MkaliMitinis3 and Guuelad and also conserved in other Syphoviridae phages, it was possible to identify a sequence (GGGAAAGG) likely to generate a ribosomal slippage in ORF 14; after a -1 frameshift, two different products would be synthesized, both predicted as tail assembly chaperones and depicted as 14_1 and 14_2 in Figure 2.

A notable difference between phage Celfi and the rest of the subcluster L2 phages, including the prophage integrated in the Mycobacterium sp. DL90 genome, was found in gene 27 that codes for a putative lysin B (LysB). LysB enzymes are part of the lysis cassette in Mycobacteriophages, which cleave the mycolylarabinogalactan bond to release free mycolic acids and disrupt the outer membrane, facilitating the liberation of virions after infection.32–34 Gene 27 is 1152 bp long and the gene product is a 384 aa protein. At the nucleotide level, the first 223 bp is highly similar between phage Celfi and all subcluster L2 phages (85–89% identity), but the rest of the lysB gene did not match any nucleotide sequence in the database (data not shown). A protein Blast search, using gp27 sequence as a query, retrieved a series of mycobacterial hypothetical proteins and Mycobacteriophage LysB proteins with an amino acid identity ∼45%. By comparing all these sequences, a tree with the highest log likelihood (−5199.58) was obtained, which is shown in Figure 3. The tree shows that Celfi LysB is more related to hypothetical proteins present in Mycobacterium spp. than to other members of subcluster L2. We were only able to identify the protein present in Mycolicibacterium mageritense as part of a prophage encoded in the bacterial genome.

FIG. 3.

FIG. 3.

Phylogenetic analysis of bacteriophage Celfi LysinB. The sequence of LysB was analyzed by BLASTp. The closest matches with an identity higher to 40% were aligned with MUSCLE and used to construct a phylogenetic tree in MEGA-X. The methods used were Maximum Likelihood and JTT matrix-based model.24 The tree is drawn to scale, with branch lengths measured in the number of substitutions per site.

For the hypothetical mycobacterial proteins, sequence similarity with Celfi LysB was observed after the first 89 amino acids of the protein. On the contrary, for the mycobacteriophage LysB proteins, the highest conservation was observed at the N-terminal of the protein (Supplementary Fig. S1). Previous analyses of members of LysB proteins have predicted a PG-Binding Domain (pfam01471) within this region30 but we did not identified one in gp27. Despite that, a serine (position 169), the GXP motif located ∼40 residues downstream, the aspartic acid (position 243), and a histidine (position 349) were conserved in gp27 and all the other compared proteins, being good candidates for the catalytic triad Ser–Asp–His previously described in other LysB and lipolytic enzymes35,36 (Supplementary Fig. S1). Finally, using HHPred, we were able to identify a predicted structure similar to bacteriophage D29 LysB with high probability (100%), between amino acids 81 and 376.

This is a good example of the genetic diversity of these highly abundant entities and emphasizes why there is a very low probability of finding an identical copy of a previously characterized phage.

Conclusion

As of today, 11281 mycobacteriophages have been isolated of which, 1911 have been sequenced.13,36 Despite that, their abundance and diversity allowed us to isolate a new bacteriophage.

Through bioinformatic analysis, it was possible to determine that mycobacteriophage Celfi belongs to cluster L, subcluster L2. This cluster is composed of 59 members and divided into four subclusters, L2 being the most populated.13 As well as all of the members of this cluster, Mycobacteriophage Celfi probably exhibits a temperate life cycle with a genome length and GC content similar to the average of cluster L. When compared with its closest match, a prophage integrated in Mycobacterium sp. DL90, it was possible to identify the putative attP and attB in M. smegmatis mc2155 genome. We were also able to predict a ribosomal slippage in the putative tail assembly chaperone gene, allowing the translation of two proteins with different lengths, a characteristic that is shared with members of the cluster and other Siphophages.

Interestingly, only a small proportion of the mycobacteriophages isolated in M. smegmatis infect M. tuberculosis, and most of them are restricted to a small number of clusters.37 Remarkably, this new mycobacteriophage infects M. tuberculosis with an apparent higher EoP than the host used for isolation. One difference with the other bacteriophages in cluster L was a quite dissimilar sequence for LysB, which cleaves the mycolylarabinogalactan bonds, facilitating progeny release. As shown in Figure 3, phage Celfi LysB is close to putative lipolytic proteins present in several mycobacterial species (including Mycobacterium palauense, Mycobacterium dioxanotrophicus, Mycobacterium aquaticum, and Mycolicibacterium mageritense), suggesting the possibility of alternative hosts for this phage in nature. Considering the complexity of the mycobacterial cell wall, the high EoP of Celfi in M. tuberculosis might be at least partially explained by the action of this particular LysB protein. The cotreatment of LysA and LysB to render M. tuberculosis susceptible to endolysin treatment has been proposed,34 so further characterization of phage Celfi LysB activity could be interesting from a biotechnological perspective.

Considering the clinical relevance of M. tuberculosis, the isolation of new bacteriophages capable of infecting it broadens the spectrum of tools for genetic manipulation, diagnosis, and, may be in the future, for treatment of this complex human pathogen. In 2019, it was described for the first time the use of engineered mycobacteriophages to treat a patient with cystic fibrosis chronically infected with M. abscessus.38 All of the phages used in the therapeutic cocktail had been isolated in the context of an educational program without the perspectives of therapeutic use, highlighting the impact that these projects can have at many different levels.

Supplementary Material

Supplemental data
Supp_Table1.pdf (267.4KB, pdf)
Supplemental data
Supp_Fig1.pdf (1MB, pdf)

Acknowledgments

Our special thanks to CELFI (Centro Latinoamericano de Formación Interdisciplinaria) (2016–2017), CABBIO (Centro Argentino Brasileño de Biotecnología) (2015), UNU-BIOLAC (United Nations University Biotechnology Programme for Latin America and the Caribbean) (2017), and CABANA (capacity building for bioinformatics in Latin America) (2019) for financial and logistics support providing travel grants to students and/or invited professors. Finally, we are grateful to all the students who participated in the course and isolated new phages. A complete list of the students and affiliations from 2015 to 2019 is provided in Supplementary Table S1 (Commentary).

Authors' Contributions

Mycobacterium phage vB_MsmS_Celfi (phage Celfi) was isolated during the phage course 2016. Owing to time constraints, phage preparations were further purified, subjected to a cesium chloride gradient before electron microscopy (EM) analysis, and DNA extraction for sequencing. F.P., L.R.S., V.G., M.D.P., E.U., M.E.D., J.P.C., and F.Z. contributed to concepts/design, data acquisition/analysis/interpretation, and article preparation. M.D., P.G., and J.K. contributed to EM data acquisition/analysis and revising the article. E.S. and D.F.D.P. contributed to phage genome assembly. A.R. contributed to bioinformatics analysis, article preparation, and revising the article. R.R.R. contributed to revising the article. M.P. contributed to concepts/design, data analysis/interpretation, preparation, revising, and approval of the article. This article has been submitted solely to this journal and is not published, in press, or submitted elsewhere.

Author Disclosure Statement

The authors declare that no competing financial interests exist.

Funding Information

No specific funding was received for this research.

Supplementary Material

Supplementary Figure S1

Supplementary Table S1

References

  • 1. Honda JR, Virdi R, Chan ED. Global environmental nontuberculous mycobacteria and their contemporaneous man-made and natural niches. Front Microbiol. 2018;9:2029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Van Ingen J, Aksamit T, Andrejak C, et al. Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: An NTM-NET consensus statement. Eur Respir J. 2018;51(3):1800170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Hatfull GF. The secret lives of mycobacteriophages. Adv Virus Res 2012;82:179–288. [DOI] [PubMed] [Google Scholar]
  • 4. Jacobs WR. Advances in mycobacterial genetics: New promises for old diseases. Immunobiology. 1992;184(2–3):147–56. [DOI] [PubMed] [Google Scholar]
  • 5. Jacobs WR, Tuckman M, Bloom BR. Introduction of foreign DNA into mycobacteria using a shuttle phasmid. Nature. 1987;327(6122):532–535. [DOI] [PubMed] [Google Scholar]
  • 6. Jacobs WR, Barletta RG, Udani R, et al. Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages. Science (80-). 1993;260(5109):819–822. [DOI] [PubMed] [Google Scholar]
  • 7. Bardarov S, Bardarov S, Pavelka MS, et al. Specialized transduction: An efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M. bovis BCG and M. smegmatis. Microbiology. 2002;148(Pt 10):3007–3017. [DOI] [PubMed] [Google Scholar]
  • 8. Lee MH, Pascopella L, Jacobs WR, et al. Site-specific integration of mycobacteriophage L5: Integration-proficient vectors for Mycobacterium smegmatis, Mycobacterium tuberculosis, and bacille Calmette-Guerin. Proc Natl Acad Sci U S A. 1991;88(8):3111–3115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Bardarov S, Kriakov J, Carriere C, et al. Conditionally replicating mycobacteriophages: A system for transposon delivery to Mycobacterium tuberculosis. Proc Natl Acad Sci U S A. 1997;94(20):10961–10966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. van Kessel JC, Hatfull GF. Recombineering in Mycobacterium tuberculosis. Nat Methods. 2007;4(2):147–152. [DOI] [PubMed] [Google Scholar]
  • 11. Rondón L, Urdániz E, Latini C, et al. Fluoromycobacteriophages can detect viable Mycobacterium tuberculosis and determine phenotypic rifampicin resistance in 3-5 days from sputum collection. Front Microbiol. 2018;9:1–15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Hatfull GF. Innovations in undergraduate science education: Going viral: TABLE 1. J Virol. 2015;89(16):8111–8113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Russell DA, Hatfull GF. PhagesDB: The actinobacteriophage database. Bioinformatics. 2017;33(5):784–786. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Actinobacteriophage clusters. https://phagesdb.org/clusters. (Accessed August 27, 2020).
  • 15. Kropinski AM, Mazzocco A, Waddell TE, et al. Enumeration of bacteriophages by double agar overlay plaque assay. Methods Mol Biol. 2009;501:69–76. [DOI] [PubMed] [Google Scholar]
  • 16. Sambandamurthy VK, Derrick SC, Hsu T, et al. Mycobacterium tuberculosis ΔRD1 ΔpanCD: A safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis. Vaccine. 2006;24(37–39):6309–6320. [DOI] [PubMed] [Google Scholar]
  • 17. Program PH. PCI DNA Extraction. PCI DNA Extraction. (Accessed August 27, 2020). [Google Scholar]
  • 18. Bolger AM, Lohse M, Usadel B. Trimmomatic: A flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30(15):2114–2120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Zerbino DR, Birney E. Velvet: Algorithms for de novo short read assembly using de Bruijn graphs. Genome Res. 2008;18(5):821–829. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Pope WH, Jacobs-Sera D. Annotation of bacteriophage genome sequences using DNA master: An overview. Methods Mol Biol. 2018;1681:217–229. [DOI] [PubMed] [Google Scholar]
  • 21. Delcher AL, Bratke KA, Powers EC, et al. Identifying bacterial genes and endosymbiont DNA with Glimmer. Bioinformatics. 2007;23(6):673–679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Besemer J, Borodovsky M. GeneMark: Web software for gene finding in prokaryotes, eukaryotes and viruses. Nucleic Acids Res. 2005;33(Web Server issue):W451–W454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Laslett D, Canback B. ARAGORN, a program to detect tRNA genes and tmRNA genes in nucleotide sequences. Nucleic Acids Res. 2004;32(1):11–16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Lowe TM, Chan PP. tRNAscan-SE On-line: Integrating search and context for analysis of transfer RNA genes. Nucleic Acids Res. 2016;44(W1):W54–W57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Lowe TM, Eddy SR. tRNAscan-SE: A program for improved detection of transfer RNA genes in genomic sequence. Nucleic Acids Res. 1997;25(5):955–964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Altschul SF, Gish W, Miller W, et al. Basic local alignment search tool. J Mol Biol. 1990;215(3):403–410. [DOI] [PubMed] [Google Scholar]
  • 27. Zimmermann L, Stephens A, Nam SZ, et al. A Completely Reimplemented MPI Bioinformatics Toolkit with a New HHpred Server at its Core. J Mol Biol. 2018;430(15):2237–2243. [DOI] [PubMed] [Google Scholar]
  • 28. Kumar S, Stecher G, Li M, et al. MEGA X: Molecular evolutionary genetics analysis across computing platforms. Mol Biol Evol. 2018;35(6):1547–1549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Jones DT, Taylor WR, Thornton JM. The rapid generation of mutation data matrices from protein sequences. Bioinformatics. 1992;8(3):275–282. [DOI] [PubMed] [Google Scholar]
  • 30. Hatfull GF, Pedulla ML, Jacobs-Sera D, et al. Exploring the mycobacteriophage metaproteome: Phage genomics as an educational platform. PLoS Genet. 2006;2(6):e92. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Herren CD, Peister A, Breton TS, et al. Genome sequences of four subcluster L2 Mycobacterium phages, Finemlucis, Miley16, Wilder, and Zakai. Genome Announc. 2017;5(46):e01233-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Catalão MJ, Gil F, Moniz-Pereira J, et al. Functional analysis of the Holin-Like proteins of mycobacteriophage Ms6. J Bacteriol. 2011;193(11):2793–2803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Gil F, Catalão MJ, Moniz-Pereira J, et al. The lytic cassette of mycobacteriophage Ms6 encodes an enzyme with lipolytic activity. Microbiology. 2008;154(Pt 5):1364–1371. [DOI] [PubMed] [Google Scholar]
  • 34. Payne K, Sun Q, Sacchettini J, et al. Mycobacteriophage Lysin B is a novel mycolylarabinogalactan esterase. Mol Microbiol. 2009;73(3):367–381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Catalão MJ, Pimentel M. Mycobacteriophage lysis enzymes: Targeting the mycobacterial cell envelope. Viruses. 2018;10(8):428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Satish R, Desouza A. Study of characteristics of mycobacteriophage—A novel tool to treat Mycobacterium spp. Int J Mycobacteriology. 2019;8(2):170–174. [DOI] [PubMed] [Google Scholar]
  • 37. Hatfull GF. Mycobacteriophages: Windows into tuberculosis. PLoS Pathog. 2014;10(3):12–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Dedrick RM, Guerrero-bustamante CA, Garlena RA, et al. Engineered bacteriophages for treatment of a patient with a disseminated drug resistant Mycobacterium abscessus. 2019;25(5):730–733. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental data
Supp_Table1.pdf (267.4KB, pdf)
Supplemental data
Supp_Fig1.pdf (1MB, pdf)

Articles from Phage are provided here courtesy of Mary Ann Liebert, Inc.

RESOURCES